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a b s t r a c t
The actinobacterium strain ABH26 closely related to Saccharothrix xinjiangensis, isolated from an Algerian
Saharan soil sample, exhibited highly antagonist activity against Gram-positive bacteria, yeasts and
ﬁlamentous fungi. Its ability to produce antimicrobial compounds was investigated using several solid
culture media. The highest antimicrobial activity was obtained on Bennett medium. The antibiotics
secreted by strain ABH26 on Bennett medium were extracted by methanol and puriﬁed by reverse-
phase HPLC using a C18 column. The chemical structures of the compounds were determined after spec-
troscopic (1H NMR, 13C NMR, 1H-1H COSY and 1H-13C HMBC spectra), and spectrometric (mass spectrum)
analyses. Two new cyanogriside antibiotics named cyanogriside I (1) and cyanogriside J (2), were charac-
terized along with three known caerulomycins, caerulomycin A (3), caerulomycin F (4) and caerulomy-
cinonitrile (5). This is the ﬁrst report of cyanogrisides and caerulomycins production by a member of
the Saccharothrix genus. The minimum inhibitory concentrations (MIC) of these antibiotics were deter-
mined against pathogenic microorganisms.
 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Cyanogrisides and caerulomycins are bioactive secondary
metabolites containing a 2,20-bipyridine skeleton and produced
by two mycelial actinobacteria species, Streptomyces caeruleus
(Funk and Divekar, 1959) and Actinoalloteichus cyanogriseus
(Fu et al., 2011). Cyanogrisides differ to caerulomycins by the
presence of one or more sugars bonded to the bipyridine skeleton.
At the time of writing, 9 cyanogrisides and 13 caerulomycins have
been isolated and characterized. These compounds have been
shown to have antibacterial, antifungal, antiparasitic and antitu-
mor activities (Funk and Divekar, 1959; Chatterjee et al., 1984;
Ambavane et al., 2014; Kujur et al., 2015).
Actinobacteria are Gram-positive bacteria with high (55%)
guanine and cytosine content in their genomes. This group of
microorganisms represents one of the most important sources of
natural bioactive compounds. Berdy (2012) estimated that 62% of
known bioactive microbial compounds are originally from acti-
nobacteria. Saccharothrix spp. are relatively rare actinobacteria
known to produce several antibiotics with different structures
and biological activities, such as the antibacterial agent tianchimy-
cins from Saccharothrix xinjiangensis NRRL B-24321 (Wang et al.,
2013) and the antiviral agent ﬂuvirucin from Saccharothrix mut-
abilis R516-16 (Naruse et al., 1991).
The arid soils of the Algerian Sahara have been shown to be rich
in members of the Saccharothrix genus (Sabaou et al., 1998; Zitouni
et al., 2005) including new species, such as Saccharothrix algeriensis
NRRL B-24137T (Zitouni et al., 2004a), Saccharothrix hoggarensis
DSM 45457T, Saccharothrix saharensis DSM 45456T, Saccharothrix
tamanrassetensis DSM 45947T (Boubetra et al., 2013a, 2013b,
2015), Saccharothrix isguenensis DSM 46885T and Saccharotrix
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ghardaiensis DSM 46886T (Bouznada et al., 2016, 2017). In addition,
many studies have shown the ability of Saccharothrix strains iso-
lated from these soils to produce new or known antibiotics, such
as dithiolopyrrolones (Lamari et al., 2002; Bouras et al., 2008;
Merrouche et al., 2011), anthracyclines (Zitouni et al., 2004b) and
chloramphenicol (Aouiche at al., 2012). These promising results
emphasise the need to continue the research into Saccharothrix
antimicrobial production.
In Algeria, we isolated a mycelial actinobacterium strain with
strong antibacterial and antifungal activities designated as
ABH26. Based on morphological, physiological and molecular char-
acterization the strain was found to be related to Saccharothrix
xinjiangensis (Lahoum et al., 2015). Initially, this strain had antimi-
crobial activity on solid and liquid ISP (International Streptomyces
Project) 2 culture medium (Shirling and Gottlieb, 1966). However,
the strain has subsequently lost its activity in liquid medium while
this activity was conserved on solid medium (data not shown).
The aim of this study was to characterize the bioactive com-
pounds secreted by strain ABH26 on various solid culture media,
and to test the antimicrobial activity of these molecules against
some representative pathogenic microorganisms.
2. Materials and methods
2.1. Microbial strains
The actinobacterial strain ABH26 was isolated from a Saharan
soil sample collected in the Adrar region (Southern Algeria). It
was found to be most closely related to Saccharothrix xinjiangensis
(Lahoum et al., 2015). The target microorganisms used for antimi-
crobial testing are from our laboratory collection and are listed in
Table 1. This list includes Gram-positive and Gram-negative
bacteria, yeasts and ﬁlamentous fungi, most of which are patho-
gens for humans or plants.
2.2. Antimicrobial activity of strain ABH26 on solid culture media
Antimicrobial activity was evaluated on ISP1 (tryptone-yeast
extract agar), ISP2 (yeast extract-malt extract agar) (Shirling and
Gottlieb, 1966), NA (nutrient agar) and Bennett (Waksman, 1961)
media by the cross streak method. The actinobacterial strain was
inoculated in a straight line on solid culture media and then incu-
bated for 10 days at 30 C. After the incubation period, target
microorganisms were seeded in perpendicular streaks that cross
the ABH26 streak. After further incubation at 30 C for 24 h for bac-
teria and yeasts, and at 25 C for 48 h for ﬁlamentous fungi, the
antimicrobial activity was determined by measuring distance of
inhibition between target microorganisms and the actinobacterial
strain.
2.3. Kinetics of bioactive compound production on solid culture media
The spores of strain ABH26 were dislodged from the pre-culture
media with a sterile loop and transferred to 10 ml of sterile
distilled water. Spores were counted using a counting chamber
and a 106 spores/ml solution was prepared. In Petri dishes
(170 mm in diameter) ﬁlled with ISP1, ISP2, NA, or Bennett media,
1 ml of spore suspension was spread on the surface of each med-
ium. The plates were incubated for 12 days at 30 C. Agar plugs
(10 mm in diameter) were regularly taken each day and used to
determine antagonistic activity against Bacillus subtilis ATCC
6633, Candida albicans M3 and Umbelopsis ramanniana NRRL
1829. All the experiments were performed in duplicate.
2.4. Extraction and puriﬁcation of antimicrobial products
Strain ABH26 was cultured on ISP1, ISP2, NA and Bennett solid
media (150 ml of each medium in 170 mm diameter Petri dishes)
as described above for 7 days at 30 C. At the end of the incubation
period, the medium was cut into small pieces and extracted with
100 ml of methanol on a magnetic stirrer set at 250 rpm for 2 h.
The extracts were concentrated to dryness by a rotary evaporator
under vacuum at 40 C. The residues were dissolved in 1 ml of
methanol. A 80 μl volume of each sample was injected into the
HPLC system (Agilent 1260) using a reverse phase C18 column
(200  10 mm; 5 μm) with a continuous linear gradient solvent
system from 20 to 100% methanol in water. A total run time of
60 min was maintained at a ﬂow rate of 1.2 ml/min under ambient
temperature. The detection of products was carried out at 220 and
254 nm. The fractions corresponding to peaks were collected, con-
centrated then tested (6 mm paper disk diffusion method) against
Bacillus subtilis ATCC 6633 and Umbelopsis ramanniana NRRL 1829
to detect the active fractions and distinguish them from the non-
active fractions. Final puriﬁcation of the antibiotics produced on
Bennett medium was achieved after the second re-injection in
the HPLC under the same conditions.
2.5. Spectroscopic and spectrometric analysis of antibiotics
These analyses were made with the pure bioactive compounds
isolated from Bennett medium. The UV–visible spectra in methanol
were determined with a Shimadzu UV 1605 spectrophotometer.
The mass spectra were recorded on LCQ ion-trap mass spectrome-
ter (Finnigan MAT, San Jose, CA) equipped with a nanospray ion
electro-spray ionization source (positive and negative ion mode).
1H and 13C NMR spectroscopy were used for the ﬁnal characteriza-
tion of bioactive compounds. NMR samples were prepared by dis-
solving 3 mg of each compound in 600 μl of CD3OD. All spectra
Table 1
Antimicrobial activity of the strain ABH26 on Bennett, ISP2, NA and ISP1 culture
media.
Target microorganism Distance of inhibition (mm)
Bennett ISP2 NA ISP1
Aspergillus brasiliensis AB1 25 24 18 16
A. carbonarius AC1 35 33 19 15
A. carbonarius AC2 28 22 16 15
A. ﬂavus NRRL 3251 23 21 17 17
A. parasiticus CBS 100,926 22 17 16 15
A. westerdijkiae ATCC 3174 22 20 17 13
Fusarium culmorum FC1 31 28 19 16
F. equiseti FE1 25 24 16 14
F. graminearum FG1 27 24 19 15
F. oxysporum f. sp. albedinis Foa1 27 27 17 18
F. o. f. sp. radicis-lycopersici Forl 23 22 17 17
F. solani Fsol 28 27 18 17
F. sporotrichioides FS1 27 26 18 15
Rhizoctonia solani AG3 31 28 20 18
Umbelopsis ramanniana NRRL 1829 38 32 21 19
Candida albicans M2 25 22 12 4
C. albicans M3 31 30 15 12
C. albicans IPA200 24 23 13 5
Saccharomyces cerevisiae ATCC 4226 34 32 16 14
Bacillus subtilis ATCC 6633 22 20 19 19
Corynebacterium diphtheriae CD1 28 31 22 20
Enterococcus faecalis EF1 21 25 18 17
Listeria monocytogenes ATCC 13,932 27 31 21 19
Micrococcus luteus ATCC 9314 30 33 18 18
Staphylococcus aureus ATCC 29,213 21 24 16 15
S. aureus ATCC 43,300 19 20 14 11
S. aureus MRSA 639c 13 15 13 12
Escherichia coli E52 0 0 0 0
E. coli E195 0 0 0 0
Klebsiella pneumoniae E40 0 0 0 0
Pseudomonas aeruginosa IPA1 0 0 0 0
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were recorded on a Bruker Avance 500 spectrometer equipped
with a 5 mm triple resonance inverse Z-gradient probe (TBI 1H,
31P, BB). All chemical shifts for 1H and 13C are relative to TMS using
1H (residual) or 13C chemical shifts of the solvent as a secondary
standard. The temperature was set at 298 K. All the 1H and 13C sig-
nals were assigned on the basis of chemical shifts, spin-spin cou-
pling constants, splitting patterns and signal intensities, and by
using 1H-1H COSY45, 1H-13C HSQC and 1H-13C HMBC experiments.
Gradient-enhanced 1H COSY45 was performed and included 36
scans per increment. 1H-13C correlation spectra using a gradient-
enhanced HSQC sequence (delay was optimised for 1JCH of 145
Hz) was obtained with 120 scans per increment. A gradient-
enhanced HMBC experiment was performed allowing 62.5 ms for
long-range coupling evolution (240 scans were accumulated). Typ-
ically, 2048 t2 data points were collected for 256 t1 increments.
2.6. Determination of minimum inhibitory concentrations
Minimum inhibitory concentrations (MIC) of pure antibiotics
were determined using the conventional agar dilution method
(Oki et al., 1990) on the target microorganisms listed in Table 1.
The target strains were inoculated onto Mueller Hinton medium
for bacteria and Sabouraud medium for fungi, containing different
concentrations of each active compound (0.5, 1, 2, 3, 4, 5, 10, 15, 20,
25, 30, 40, 50, 60, 70, 80, 90 and 100 μg/ml). The same concentra-
tion of two standard antibiotics were used for comparison: nys-
tatin (antifungal compound) and amoxicillin (antibacterial
compound). After a growth period at 30 C for 24 h for bacteria
and yeasts and 48 h for ﬁlamentous fungi, the plates were exam-
ined for growth and the lowest antibiotic concentration that inhib-
ited the growth of each organism was determined. Mueller Hinton
and Sabouraud media inoculated with target organisms, but with-
out active compounds were used as control treatments. All the
experiments were performed in duplicate.
3. Results
3.1. Antimicrobial activity of strain ABH26 on solid media
The antimicrobial activity of strain ABH26 against various tar-
get microorganisms is shown in Table 1. The strain exhibited a
strong ability to inhibit growth of Gram-positive bacteria, yeasts
and ﬁlamentous fungi. However, this strain did not show any activ-
ity against Gram-negative bacteria. The highest antifungal activity
was observed on Bennett medium, while the highest antibacterial
activity was obtained on ISP2 medium. The strain showed less
antimicrobial activity on ISP1 and NA media.
3.2. Kinetics of bioactive compound production on solid media
Antimicrobial activity was detected on all tested media, ISP1,
ISP2, NA and Bennett (Fig. 1). The antibacterial activity started on
the second or third day and reached a maximum after 7 or 8 days
of incubation. The highest activity was observed in ISP2 medium
then Bennett medium. The antifungal activity against Umbelopsis
ramanniana started after 2 or 3 days of incubation and after 4 days
for Candida albicans. Antifungal activity reached a maximum at
7 days on all tested media. The highest antifungal activity was
observed in Bennett medium. Thus, Bennett medium was chosen
as the production medium for puriﬁcation of antimicrobial
compounds.
3.3. Detection of antimicrobial compounds by HPLC
The HPLC proﬁles of methanolic extracts obtained after 7 days
of incubation on ISP1, ISP2, NA and Bennett solid media are shown
in Fig. 2. Five antimicrobial compounds (1–5) were collected from
Bennett medium. The retention times of these compounds were
46.4 min (compound 1), 48.5 min (compound 2), 42.8 min (com-
pound 3), 49.9 min (compound 4) and 54.3 min (compound 5).
These compounds were also detected in the ISP2 methanolic
extract. However, compounds 1–5 were not detected or produced
in very small amounts in NA and ISP1 media. Compounds 1, 2, 3
and 5 were active only against Gram-positive bacteria. However,
compound 4 showed antibacterial and antifungal activities. In
addition of these ﬁve compounds, a hydrophilic unseparated com-
plex (named X) was detected in all tested media. This complex has
antibacterial and antifungal activity. The HPLC proﬁles from differ-
ent days of incubation on Bennett medium (Fig. 3) showed that
after 4 days the strain produced the ﬁve compounds. The major
products were compounds 3, 4 and 5. After 7 days, the strain pro-
duced higher amounts of the ﬁve antimicrobial compounds. After
10 and 12 days, the amounts of the products were slightly reduced.
We continued our study with products 1–5.
3.4. Spectroscopy and spectrometry analyses of antimicrobial products
Strain ABH26 was cultivated in 16 Petri dishes (170 mm in
diameter), each containing 150 ml of Bennett solid medium at
30 C for 7 days. The total volume of medium was 2.4 L.
Compound 1 was obtained as a light purple oil. The UV spec-
trum showed the maximal absorbance at 234 and 266 nm. The
Fig. 1. Time course of antimicrobial activity of strain ABH26 on ISP1 (h), ISP2 (d),
Bennett () and NA (4) solid culture media against Bacillus subtilis ATCC 6633 (a),
Umbelopsis ramanniana NRRL 1829 (b) and Candida albicans M3 (c).
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ESIMS spectrum contained an ion peak at m/z 579.09 for [M-H]+.
The 1H and 13C chemical shifts are given in Table 2. The 13C and
HSQC spectra show 27 carbon signals. From the 13C data, it was
possible to discern one amide group (dc 173.25), ﬁve hydroxyl
groups (dc 61.0 to 74.56), one methoxy group (dc 54.90), 11 sp2–hy-
bridized carbons (dc from 106.15 to 167.44) and 7 sp3-hybridized
Fig. 2. HPLC analysis of methanolic extracts of strain ABH26 cultured on Bennett (a), ISP2 (b), NA (c) and ISP1 (d) solid culture media. Numbers in brackets indicate the
antimicrobial compounds secreted by the strain. Retention times were also indicated in Bennett medium.
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carbons (dc 16.63–102.74). The hydrogens of the hydroxyl and
amide groups are not observed due to rapid exchange with CD3OD.
The 2D 1H-1H and 1H-13C experiments and especially the long
range 1H-13C couplings observed in the HMBC spectrum permitted
to establish the connectivity between all the groups of the com-
pound. The HMBC and COSY correlations of compound 1 are shown
in Fig. 4, and the structure in Fig. 5. The NMR data suggested that
compound 1 represents a new antibiotic belonging to the family of
cyanogrisides, for which the name cyanogriside I was proposed.
This compound is a methoxy-bipyridine linked (through a cyano
radical C@N) to two osidic derivatives, 2,4-dimethyl-a-L-
mannose and N-acetylglucosamine. It differs from compound 4
by the presence of these sugars.
Compound 2 was also obtained as a light purple oil. The UV
spectrum showed the maximal absorbance at 238 and 272 nm.
The ESIMS spectrum contained an ion peak at m/z 376.11 for
[M-H]+. The 1H and 13C chemical shifts are given in Table 2. Eigh-
teen carbon signals were present in the 13C and HSQC spectra.
From the 13C data, it was possible to discern three hydroxyl groups
(dc 69.27–72.00), one methoxy group (dc 54.93), 11 sp2–hybridized
carbons (dc from 105.83 to 167.30) and 3 sp3-hybridized carbons
(dc 16.32–102.79). Due to rapid exchange with CD3OD the
Fig. 3. HPLC analysis of methanolic extract of strain ABH26 cultured on Bennett medium for 0 day (a), 2 days (b), 4 days (c), 7 days (d), 10 days (e) and 12 days (f).
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hydrogens of the hydroxyl group are not observed. The 2D 1H-1H
and 1H-13C experiments and especially the long range 1H-13C
couplings observed in the HMBC spectrum permitted to establish
the connectivity between all the groups of the compound. The
HMBC and COSY correlations of compound 2 are shown in Fig. 4,
and the structure in Fig. 5. The NMR data suggested that compound
2 represents a new antibiotic belonging to the family of cyanogri-
sides, for which the name cyanogriside J was proposed. This
compound is a methoxy-bipyridine linked (through a cyano radical
C@N) to 2,4-dimethyl-a-L-mannose. It differs from the compound
4 by the presence of this sugar, and from the compound 1 by the
absence of N-acetylglucosamine.
Compound 3 was obtained as white amorphous powder. The UV
spectrum showed the maximal absorbance at 222 and 280 nm. The
ESIMS spectrum contained an ion peak at m/z 217.16 for [M + H]+.
The NMR data (Table 3) led to identify compound 3 as caeru-
lomycin F (Fu et al., 2011). The structure of compound 3 is shown
in Fig. 4. This compound is a methoxy-bipyridine containing a
hydroxymethyl group CH2OH.
Compound 4 was obtained as white powder. The UV spectrum
showed the maximal absorbance at 225, 245 and 283 nm. The
ESIMS spectrum contained an ion peak at m/z 230.11 for [M + H]+.
The NMR data (Table 3) led to identify compound 4 as caeru-
lomycin A (Funk and Divekar, 1959). The structure of compound
Fig. 3 (continued)
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4 is shown in Fig. 4. This compound is a methoxy-bipyridine con-
taining an oxime group CH@NAOH.
Compound 5 was obtained as a light purple oil. The UV spec-
trum showed the maximal absorbance at 222, 246 and 280 nm.
The ESIMS spectrum contained an ion peak at m/z 212.23 for
[M+H]+. The NMR data (Table 3) led to identify compound 5 as
caerulomycinonitrile (Fu et al., 2011). The structure of compound
5 is shown in Fig. 4. This compound is a methoxy-bipyridine linked
to a nitrile group C„N.
3.5. Minimum inhibitory concentrations of antimicrobial compounds
Minimum inhibitory concentrations of compounds 1–5 are
summarized in Table 4. The most active product was compound
4. The MIC values of this compound were between 1 and 20 μg/ml
for ﬁlamentous fungi, 2–10 μg/ml for yeasts and 3–50 μg/ml for
Gram-positive bacteria. The strains of Gram-negative bacteria
were resistant. The comparison of MIC values of compound 4 with
those of the standard antibiotics used in this study indicated that
the compound 4 showed a better activity than amoxicillin against
the Gram positive bacteria Micrococcus luteus ATCC 9314, S. aureus
ATCC 43,300 and S. aureus MRSA 639c, a same activity against four
other Gram-positive bacteria, and a lower activity against all the
Gram negative bacteria tested. For the antifungal activity, the com-
pound 4 showed a better activity against nine ﬁlamentous fungi
and yeasts by comparison with nystatin, a same activity against
ﬁve fungi and a lower activity against ﬁve other fungi. Both the
new compounds (1 and 2) and the known compounds (3 and 5)
showed activity only against Gram-positive bacteria and this activ-
ity was less than that of compound 4. For these compounds, the
most sensitive strains were Micrococcus luteus ATCC 9314,
Corynebacterium diphtheriae CD1 and Listeria monocytogenes ATCC
13,932 (25 to 30 μg/ml), and the most resistant strain was Staphy-
lococcus aureusMRSA 639c (100 μg/ml). The compounds 1, 2, 3 and
5 showed a better activity than amoxicillin against S. aureus ATCC
43,300 and S. aureusMRSA 639c, a same activity against Corynebac-
terium diphtheriae CD1, Enterococcus faecalis EF1 and Listeria mono-
cytogenes ATCC 13,932 (except for the compound 5) and a lower
activity against Micrococcus luteus ATCC 9314 and Staphylococcus
aureus ATCC 29213.
Table 2
1H and 13C NMR data assignments of compounds 1 and 2 in CD3OD at 298 K. See
Figs. 4 and 5 for numbering of hydrogen and carbon atoms.
1H and 13C
number
1H chemical shift, ppm 13C chemical shift, ppm
1 2 1 2
1 1.04 4.04 21.67 69.27
2 – 3.71 173.25 71.00
3 – 3.48 – 72.00
4 3.72 3.71 56.41 69.00
5 3.51 1.31 74.56 16.32
6 3.43 5.50 70.33 102.79
7 3.34 8.32 76.37 151.20
8 3.76–3.89 – 61.00 152.42
9 4.71 7.53 102.74 105.83
10 3.79 – 80.40 167.30
11 3.58 4.02 71.17 54.93
12 3.73 7.93 69.50 107.65
13 1.31 – 16.63 157.49
14 5.50 – 102.53 155.12
15 4.29 8.68 69.06 148.60
16 8.34 7.47 151.64 124.11
17 – 7.96 157.42 137.20
18 7.54 8.43 106.15 121.36
19 – – 167.44 –
20 4.02 – 54.90 –
21 7.93 – 108.02 –
22 – – 157.49 –
23 – – 155.12 –
24 8.66 – 148.77 –
25 7.48 – 124.21 –
26 7.96 – 137.27 –
27 8.43 – 121.26 –
Fig. 4. HMBC and COSY correlations of compounds 1 (1) and 2 (2).
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4. Discussion
Strain ABH26 is related to Saccharothrix xinjiangensis (Lahoum
et al., 2015). It has not been indicated in the literature that this spe-
cies produces cyanogrisides and caerulomycins, but rather that it is
a producer of tianchimycins, which are macrolides (Wang et al.,
2013). This is the ﬁrst report of cyanogrisides and caerulomycins
production by a member of the Saccharothrix genus. The antibiotics
belonging to these two families are known to be produced by
Streptomyces caeruleus (Funk and Divekar, 1959) and Actinoallote-
ichus cyanogriseus (Fu et al., 2011), but are also manufactured syn-
thetically because their important biological activity (Bobrov and
Tyvorskii, 2010). The new cyanogrisides obtained in this study
(products 1 and 2) only showed inhibitory activity against Gram-
positive bacteria. In the literature, antimicrobial activity of
cyanogrisides has never been reported. However, many works have
described the antitumor activity of these products (Fu et al., 2011,
2014). In addition, Fu et al. (2014) reported that the cytotoxicity of
cyanogrisides was lower than that of caerulomycin A. The previ-
ously identiﬁed caerulomycin A (product 4) exhibited an important
activity. We noted that its antifungal activity was stronger than its
antibacterial activity. The broad antifungal activity of caeru-
lomycin A has been extensively reported (Chatterjee et al., 1984;
Ambavane et al., 2014). Other studies have suggested the
important role of caerulomycin A in the regulation of immune
homeostasis (Gurram et al., 2014; Kujur et al., 2015). Product 3
Fig. 5. Structures of compounds 1 (1), 2 (2), 3 (3), 4 (4) and 5 (5).
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(caerulomycin F) presented the same activity spectrum as the two
new cyanogrisides, while product 5 (caerulomycinonitrile) has the
lowest activity. In our study, we noted that the isolated products
were not active against Gram-negative bacteria. The same observa-
tion was found by Boubetra et al. (2013c), who reported that the
new antibiotics produced by Saccharothrix SA198 (isolated from
Saharan soil) showed no activity against Gram-negative bacteria.
Compounds 1, 2, 3, 4 and 5 were secreted by strain ABH26 only
on solid media, especially those containing glucose, such as Ben-
nett medium (glucose, peptone, yeast extract and beef extract)
and ISP2 medium (glucose, yeast extract and malt extract), while
very small amounts were obtained on NA (peptone, yeast extract
and beef extract) and ISP1 (tryptone and yeast extract) media.
Thus, glucose seems to have an important role in the synthesis of
these products. The production of compounds (1–5) started at
4 days in Bennett medium and reached a maximum after 7 days.
Caerulomycins F (product 3) and A (product 4) and caerulomyci-
nonitrile (product 5) are the major compounds. The new cyanogri-
sides (products 1 and 2) are produced in smaller quantities. The
structure of the active product contained in the hydrophilic com-
plex X could not be determined because of the difﬁculties encoun-
tered during its puriﬁcation. However, this product appears to be
the cause of activity observed in ISP1 and NA media (where the
compounds 1–5 are not produced or produced in small amounts)
and also the cause of activity observed during the second day of
the kinetics study (compounds 1–5 being produced until the 4th
day).
Moreover, we noted a correlation between the structure and
antimicrobial activity of the compounds. Caerulomycin A
(methoxy-bipyridine containing an oxime group CH@NAOH)
showed potent activity against Gram-positive bacteria, yeasts
and ﬁlamentous fungi. The linkage of a sugar (2,4-dimethyl-a-L-
Table 3
1H and 13C NMR data assignments of compounds 3, 4 and 5 in CD3OD at 298 K.
1H and 13C number 1H chemical shift, ppm 13C chemical shift, ppm
3 4 5 3 4 5
1 4.75 8.21 – 64.34 149.02 117.44
2 – – – 162.85 153.90
3 7.14 7.45 7.53 106.28 105.35 115.81
4 – – – 167.86 167.31 167.50
5 4.00 4.00 4.05 54.62 54.58 55.80
6 7.75 7.87 8.21 105.33 107.15 109.47
7 – – – 156.84 156.82 156.80
8 – – – 155.82 155.38 155.65
9 8.65 8.66 8.73 148.65 148.54 149.22
10 7.46 7.47 7.53 123.94 123.96 125.00
11 7.95 7.96 8.00 137.27 137.20 137.63
12 8.35 8.41 8.43 121.63 121.60 121.49
Table 4
Minimum inhibitory concentration (MIC) of compounds 1–5 produced by the strain ABH26.
Target microorganism Minimum inhibitory concentration (μg/ml)
1 2 3 4 5
Bacillus subtilis ATCC 6633 50 50 50 10 60
Corynebacterium diphtheriae CD1 25 25 25 25 30
Enterococcus faecalis EF1 50 50 50 50 60
Listeria monocytogenes ATCC 13,932 25 25 25 25 30
Micrococcus luteus ATCC 9314 25 25 25 3 30
Staphylococcus aureus ATCC 29,213 50 50 50 50 60
S. aureus ATCC 43,300 50 50 50 50 60
S. aureus MRSA 639c 100 100 100 20 100
Escherichia coli E52 >100 >100 >100 >100 >100
E. coli E195 >100 >100 >100 >100 >100
Klebsiella pneumoniae E40 >100 >100 >100 >100 >100
Pseudomonas aeruginosa IPA1 >100 >100 >100 >100 >100
Aspergillus brasiliensis AB1 >100 >100 >100 10 >100
A. carbonarius AC1 >100 >100 >100 1 >100
A. carbonarius AC2 >100 >100 >100 10 >100
A. ﬂavus NRRL 3251 >100 >100 >100 15 >100
A. parasiticus CBS 100,926 >100 >100 >100 20 >100
A. westerdijkiae ATCC 3174 >100 >100 >100 15 >100
Fusarium culmorum FC1 >100 >100 >100 3 >100
F. equiseti FE1 >100 >100 >100 10 >100
F. graminearum FG1 >100 >100 >100 10 >100
F. oxysporum f. sp. albedinis Foa1 >100 >100 >100 3 >100
F. o. f. sp. radicis-lycopersici Forl >100 >100 >100 10 >100
F. solani Fsol >100 >100 >100 3 >100
F. sporotrichioides FS1 >100 >100 >100 5 >100
Rhizoctonia solani AG3 >100 >100 >100 3 >100
Umbelopsis ramanniana NRRL 1829 >100 >100 >100 2 >100
Candida albicans M2 >100 >100 >100 10 >100
C. albicans M3 >100 >100 >100 2 >100
C. albicans IPA200 >100 >100 >100 10 >100
Saccharomyces cerevisiae ATCC 4226 >100 >100 >100 2 >100
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mannose) or two sugars (2,4-dimethyl-a-L-mannose and
N-acetylglucosamine) for formation of the new cyanogrisides
(products 2 and 1 respectively), led to a considerable decrease in
activity. This activity becomes weaker against Gram-positive bac-
teria and absent against ﬁlamentous fungi and yeasts. However,
the presence of sugars may be also lead to decreased cytotoxicity
to animal cells as reported by Fu et al. (2014). Similarly, we noted
that the oxime group CH@NAOH of product 4 had a very important
role in the high activity of this product. Indeed, when this group is
replaced by a hydroxymethyl group CH2OH (product 3) or by a
nitrile group (product 5) the activity decreased considerably
against Gram-positive bacteria and becomes absent against ﬁla-
mentous fungi and yeasts.
5. Conclusion
Strain ABH26, related to Saccharothrix xinjiangensis, produced
ﬁve bipyridine antibiotics belonging to the caruleomycins and
cyanogrisides families. Two new cyanogriside antibiotics, named
cyanogriside I and cyanogriside J, were characterized along with
three known caerulomycins: caerulomycin A, caerulomycin F and
caerulomycinonitrile. The ﬁve compounds showed activity against
several pathogenic Gram-positive bacteria and one of them also
exhibited an interesting antifungal activity. The activity of the
compounds was related to their chemical structure. The oxime
group bonded to the bipyridine ring strongly increased activity
while the presence of sugars decreased this activity. This is the ﬁrst
report of cyanogrisides and caerulomycins production by a mem-
ber of the Saccharothrix genus.
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